Histamine Completed Phase 2 Trials for Allergic Skin Reaction Screening

IndicationsStatusPurposePhase
CompletedScreening2
clinicaltrials.gov IdentifierTitleDrugs
NCT01689363Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)